Literature DB >> 20107759

[Pulmonary manifestations of inflammatory bowel disease].

O Bachmann1, F Länger, J Rademacher.   

Abstract

Pulmonary disease is a rare complication of inflammatory bowel disease. Airway inflammation, interstitial lung disease and several other manifestations have been described, and typical symptoms are productive cough, chest pain, and progressive dyspnea. Due to the frequency of preceding pulmonary disease and the common temporal dissociation regarding intestinal disease, pulmonary manifestations of inflammatory bowel disease are at high risk of being overlooked. If suspected, early work-up including CT scan and bronchoscopy should be initiated, since the natural course often involves rapidly progressive lung damage. The best therapeutic results have been obtained with topic and systemic steroids, while classic immunosuppressants are commonly not efficacious. Several case reports describe a beneficial effect of infliximab.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107759     DOI: 10.1007/s00108-009-2504-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  Letter: Eosinophilic pneumonia: an unusual side effect of therapy with salicylazosulfapyridine.

Authors:  K A Constantinidis
Journal:  Chest       Date:  1976-08       Impact factor: 9.410

2.  Pulmonary vasculitis and ulcerative colitis.

Authors:  J A Forrest; D J Shearman
Journal:  Am J Dig Dis       Date:  1975-05

Review 3.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Ian Storch; David Sachar; Seymour Katz
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

Review 4.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

5.  Steroid-responsive alveolitis associated with ulcerative colitis.

Authors:  J M Shneerson
Journal:  Chest       Date:  1992-02       Impact factor: 9.410

6.  Drugs that may injure the respiratory system.

Authors:  P Foucher; M Biour; J P Blayac; P Godard; C Sgro; M Kuhn; J M Vergnon; D Vervloet; P Pfitzenmeyer; M Ollagnier; C Mayaud; P Camus
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

7.  Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.

Authors:  S Sviri; I Gafanovich; M R Kramer; E Tsvang; E Ben-Chetrit
Journal:  J Clin Gastroenterol       Date:  1997-01       Impact factor: 3.062

8.  Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis.

Authors:  C R Swinburn; G J Jackson; I Cobden; T Ashcroft; G N Morritt; P A Corris
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

9.  Respiratory impairment in inflammatory bowel disease: does it vary with disease activity?

Authors:  J G Douglas; C F McDonald; M J Leslie; J Gillon; G K Crompton; G J McHardy
Journal:  Respir Med       Date:  1989-09       Impact factor: 3.415

10.  Chronic bronchial suppuration and inflammatory bowel disease.

Authors:  R J Butland; P Cole; K M Citron; M Turner-Warwick
Journal:  Q J Med       Date:  1981
View more
  1 in total

Review 1.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.